Elizabeth Christine Ramirez-Diaz, MD
NPI 1235471186ActiveIndividual· Internal Medicine, Rheumatology· Naranjito, PR
Internal Medicine, Rheumatology (MD) in Naranjito, Puerto Rico, trained at University of Puerto Rico School of Medicine (class of 2013). Part D covered 2,354 prescriptions written in 2024, 90% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2025, $559.25 in all, mostly food and beverage.
Overview
| NPI | 1235471186 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Mar 19, 2013 |
| Last updated in NPPES | May 15, 2021 |
| Certified by provider | May 15, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 19332 | PR |
| Internal Medicine | 207R00000X | 19,332 | PR |
| Student in an Organized Health Care Education/Training Program | 390200000X | 19,332 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Rheumatology (PR) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 2,354 · 2,579 30-day fills |
|---|---|
| Patients | 188 |
| Total drug cost | $894,058 |
| Generic share | 90% of claims |
Education and affiliations
| Medical school | University of Puerto Rico School of Medicine |
|---|---|
| Graduation year | 2013 |
| Medicare specialty | Rheumatology |
Industry payments (Open Payments)
- 2025$559.25 · 26 payments from 5 companies
- 2024$524.98 · 19 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $221.43 | 9 |
| Glaxosmithkline, LLC. | $200.04 | 11 |
| Amgen Inc. | $61.19 | 3 |
| Abbvie Inc. | $51.59 | 2 |
| Organon LLC | $25.00 | 1 |
What the 2025 payments were for
- Food and Beverage$559.25 · 26 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records